Go Pro
LON:IDHC

Integrated Diagnostics (IDHC) Share Price, News & Analysis

Integrated Diagnostics logo
GBX 0.53 -0.02 (-3.28%)
As of 04:55 AM Eastern

About Integrated Diagnostics Stock (LON:IDHC)

Advanced

Key Stats

Today's Range
0.53
0.55
50-Day Range
0.51
0.61
52-Week Range
0.44
0.84
Volume
115,368 shs
Average Volume
177,353 shs
Market Capitalization
£3.08 million
P/E Ratio
0.00
Dividend Yield
1.62%
Price Target
N/A
Consensus Rating
N/A

Company Overview

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan), and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests. From its base of 628 branches as of 31 December 2024, IDH served over 8.9 million patients and performed more than 39.2 million tests in 2024. IDH will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion. Beyond organic growth, the Group targets expansion in appealing markets, including acquisitions in the Middle Eastern, African, and East Asian markets where its model is well-suited to capitalise on similar healthcare and consumer trends and capture a significant share of fragmented markets. IDH has been a Jersey-registered entity (i) whose shares are admitted to the equity shares (transition) category (previously, the standard listing segment) of the Official List of the UK Financial Conduct Authority and admitted to trading on the main market for listed securities of the London Stock Exchange (ticker: IDHC) since May 2015.

Receive IDHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integrated Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IDHC Stock News Headlines

(Shocking Video) #1 Gold Expert Prediction
Jim Rickards called gold when it traded just above 1100 dollars per ounce. Now he predicts it could more than double to 10000 dollars per ounce within the next year, and he has put 1 million dollars of his own money behind that view. Rickards points to surging government deficits, record geopolitical instability, and a possible White House announcement around September 30 as key catalysts to watch in the gold market.tc pixel
See More Headlines

IDHC Stock Analysis - Frequently Asked Questions

Integrated Diagnostics' stock was trading at GBX 0.76 on January 1st, 2026. Since then, IDHC shares have decreased by 29.8% and is now trading at GBX 0.53.

Shares of IDHC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Integrated Diagnostics investors own include Georgia Healthcare Group PLC (GHG.L) (GHG), VEON (VEON), Pao Tmk (TMKXY) and M.P. Evans Group (MPE).

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
LON:IDHC
CIK
N/A
Fax
N/A
Employees
6,692
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 250.03
Trailing P/E Ratio
0.00
Forward P/E Ratio
0.38
P/E Growth
7.65
Net Income
£4.01 trillion
Net Margins
16.49%
Pretax Margin
N/A
Return on Equity
39.61%
Return on Assets
9.69%

Debt

Debt-to-Equity Ratio
42.91
Current Ratio
1.67
Quick Ratio
0.75

Sales & Book Value

Annual Sales
£9.17 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
GBX 591.97 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
581,326,000
Free Float
N/A
Market Cap
£3.08 million
Optionable
Not Optionable
Beta
0.43
10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (LON:IDHC) was last updated on 9/16/2026 by MarketBeat.com Staff.
From Our Partners